Dewpoint Therapeutics
First company to apply the emerging understanding of biomolecular condensates to drug discovery.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor | €0.0 | round | |
* | $150m | Series C | |
| Total Funding | 000k | ||
| EUR | 2020 | 2021 |
|---|---|---|
| Revenues | 0000 | 0000 |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Dewpoint Therapeutics is a pioneering biotechnology startup that operates in the field of biomolecular condensates. The company's primary focus is on understanding and treating complex diseases by exploring the dysregulation of these condensates. In simpler terms, biomolecular condensates are tiny droplets inside cells that play a crucial role in cell function and organization. Dewpoint believes that when these condensates don't work properly, it can lead to complex diseases.
The company has assembled a team of experts in condensate science, drug discovery, and data science, making it a global leader in condensate biotechnology. Dewpoint integrates artificial intelligence (AI) with cutting-edge experimental technologies to discover new therapeutic possibilities.
Dewpoint's business model revolves around developing and commercializing novel therapies. They have a robust pipeline of discovery programs and have established collaborations with leading global pharmaceutical partners. One of their recent collaborations aims to explore the use of biomolecular condensates in treating insulin resistance and diabetes progression.
The company generates revenue through the development and commercialization of these novel therapies, as well as through strategic partnerships with other pharmaceutical companies. Dewpoint's innovative approach and promising pipeline position it well for future growth and success in the biotechnology industry.
Keywords: Biotechnology, Biomolecular Condensates, Drug Discovery, Data Science, Artificial Intelligence, Experimental Technologies, Therapeutic Possibilities, Pharmaceutical Partnerships, Insulin Resistance, Diabetes Progression.